Genscript Biotech Corporation (FRA:G51)
1.410
-0.006 (-0.42%)
Last updated: Dec 22, 2025, 11:27 AM CET
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of €3.17 billion as of December 22, 2025. Its market cap has increased by 11.10% in one year.
Market Cap
3.17B
Enterprise Value
2.84B
Revenue
705.13M
Ranking
n/a
PE Ratio
1.20
Stock Price
€1.41
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 249.76M to 3.17B, an increase of 1,168.91%. That is a compound annual growth rate of 29.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 3.17B | 20.81% |
| Dec 31, 2024 | 2.62B | -46.27% |
| Dec 29, 2023 | 4.88B | -22.58% |
| Dec 30, 2022 | 6.31B | -22.85% |
| Dec 31, 2021 | 8.17B | 251.89% |
| Dec 31, 2020 | 2.32B | -38.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |